Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.

CONCLUSIONS: EMP2 is superior to EpCAM for capturing both MCF7 and MDA-MB-231 cells. Additionally, EMP2 is a novel biomarker and capable of capturing breast cancer cells in patient blood samples.
PMID: 30218306 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - September 14, 2018 Category: Cancer & Oncology Authors: Chen Q, Yao L, Burner D, Minev B, Lu L, Wang M, Ma W Tags: Clin Transl Oncol Source Type: research